Concepedia

Joe Jiang Zhu

JJ

Statistics

Publications

21

Citations

929

H-Index

16

Active since

2003

Affiliations

University of Hong Kong(Current)

Peter MacCallum Cancer Centre

Merck & Co., Inc., Rahway, NJ, USA (United States)

The University of Melbourne

Shenzhen University

Joe Jiang Zhu is an author at University of Hong Kong specializing in life sciences, oncology, and medicine.

ORCID

Publications per year

2003–2024

21

Publications

21

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

Jack D. Chan, C. Scheffler, Isabelle Munoz et al. · Nature · 2024 · 214 citations · Full text

, , +16

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

Emily J. Lelliott, Isabella Y. Kong, Magnus Zethoven et al. · Cancer Discovery · 2021 · 129 citations

, , +17

T <sub>STEM</sub> -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

Déborah Meyran, Joe Jiang Zhu, Jeanne Butler et al. · Science Translational Medicine · 2023 · 97 citations

, , +16

Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a <i>Pten</i> -Deficient Mouse Model of Prostate Cancer

Weisheng Zhang, Joe Jiang Zhu, Clay L. Efferson et al. · Cancer Research · 2009 · 76 citations

, , +17

Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models

L. H. Porter, Joe Jiang Zhu, Natalie L. Lister et al. · Nature Communications · 2023 · 44 citations · Full text

, , +17

1–5 of 21